Pyxis Oncology Inc. is focused on the development of novel cancer therapies designed to improve patient outcomes by overcoming key mechanisms of immunosuppression.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!